Enhanced working and verbal memory after lamotrigine treatment in pediatric bipolar disorder.
OBJECTIVE
To examine the treatment impact of lamotrigine on the neurocognitive profile of patients with pediatric bipolar disorder (PBD).


METHODS
Healthy controls (HC) (n = 24; mean age = 12.4 +/- 3.3 years) and unmedicated PBD patients with manic, mixed, or hypomanic episodes (n = 34; mean age = 13 +/- 3.1 years) were matched for IQ, age, sex, race, and socioeconomic status. A neurocognitive battery was administered at baseline and again after 14 weeks, during which PBD patients were treated with lamotrigine.


RESULTS
Clinical symptoms improved with treatment in the patient group with significant change from baseline to follow-up on the Young Mania Rating Scale (p < 0.001) and the Children's Depression Rating Scale-Revised (p < 0.001). Global neurocognitive function improved with lamotrigine in PBD patients over time relative to that in HC, although overall performance remained impaired. Working memory and verbal memory significantly improved with treatment in patients, and deficits in these domains were no longer significantly impaired relative to HC at follow-up. Executive function significantly improved with treatment in the patient group but still lagged behind HC at follow-up. Performance on attention tests did not improve with treatment.


CONCLUSIONS
There appears to be significant improvement in cognitive abilities in PBD patients treated with lamotrigine that is most prominent in the areas of working memory and verbal memory and that occurs along with mood stabilization.
Pavuluri
Mani N
MN
Center for Cognitive Medicine, University of Illinois Medical Center at Chicago, Chicago, IL 60612, USA. mpavuluri@psych.uic.edu
Passarotti
Alessandra M
AM
Mohammed
Tahseen
T
Carbray
Julie A
JA
Sweeney
John A
JA
D000293:Adolescent; D001288:Attention / Q000187:drug effects; D001714:Bipolar Disorder / Q000175:diagnosis / Q000188:drug therapy* / Q000523:psychology; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D016022:Case-Control Studies; D002648:Child; D003071:Cognition / Q000187:drug effects*; D039721:Diagnostic and Statistical Manual of Mental Disorders; D056344:Executive Function / Q000187:drug effects*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D000077213:Lamotrigine; D008297:Male; D008568:Memory / Q000187:drug effects*; D008570:Memory, Short-Term / Q000187:drug effects; D009483:Neuropsychological Tests; D016896:Treatment Outcome; D014227:Triazines / Q000627:therapeutic use*; D014706:Verbal Learning / Q000187:drug effects
D002121:Calcium Channel Blockers; D014227:Triazines; D000077213:Lamotrigine
J Am Acad Child Adolesc Psychiatry. 2009 Mar;48(3):299-307
19182689
Biol Psychiatry. 2004 Jan 1;55(1):32-9
14706422
MedGenMed. 2006 Aug 23;8(3):46
17406176
J Clin Psychopharmacol. 2006 Apr;26(2):178-81
16633148
Neurology. 1999 Jan 15;52(2):321-7
9932951
J Clin Psychiatry. 2004 Nov;65(11):1483-90
15554760
Pflugers Arch. 1995 Jul;430(3):437-46
7491269
J Affect Disord. 1998 Nov;51(2):93-100
10743842
Biol Psychiatry. 2000 Oct 1;48(7):674-84
11032979
Epilepsia. 2006 Apr;47(4):695-703
16650135
Am J Psychiatry. 2006 Feb;163(2):286-93
16449483
Epilepsia. 1986 Sep-Oct;27(5):490-7
3757936
J Am Acad Child Adolesc Psychiatry. 2007 Jan;46(1):107-125
17195735
Neuropsychopharmacology. 2001 Nov;25(5):766-76
11682260
Synapse. 1996 Nov;24(3):248-55
8923665
J Am Acad Child Psychiatry. 1984 Mar;23(2):191-7
6715741
Biol Psychiatry. 2006 Nov 1;60(9):951-6
16730333
J Am Acad Child Adolesc Psychiatry. 2006 Feb;45(2):142-148
16429084
J Consult Clin Psychol. 2007 Apr;75(2):210-20
17469879
Am J Psychiatry. 2005 Sep;162(9):1644-51
16135623
Br J Psychiatry. 1999 Sep;175:246-51
10645326
Epilepsia. 2002 Jan;43(1):19-26
11879382
Br J Psychiatry. 1978 Nov;133:429-35
728692
Neurology. 2006 May 23;66(10):1495-9
16717207
Br J Psychiatry. 2002 Apr;180:293-5
11925348
Dev Psychopathol. 2006 Fall;18(4):1231-46
17064436
Neurology. 2001 May 8;56(9):1177-82
11342682
Biol Psychiatry. 2005 Oct 1;58(7):540-8
16199011
Eur Neuropsychopharmacol. 2008 Jan;18(1):48-54
17618089
J Clin Psychopharmacol. 2007 Aug;27(4):387-91
17679147
J Am Acad Child Adolesc Psychiatry. 2007 Mar;46(3):341-355
17314720